Interestingly, we observed that, as previously found for SLC3A2 [10], ATP13A3 expression was significantly higher in MYCN‐amplified versus non‐MYCN amplified neuroblastoma tumors (Fig. 9A). This evidence concerns the gene MYCN and neuroblastoma.